Navigation Links
Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis
Date:3/2/2009

ef="http://www.crohnsinthezone.com/" target="_new">www.CrohnsintheZone.com), during the 2008 football season in partnership with professional quarterback, David Garrard. Garrard's efforts on the field resulted in a donation of $170,000 to the CCFA. The funds raised from In the Zone for Crohn's will help support continued Crohn's disease research and disease awareness programs.

"We look forward to continuing our partnership with Centocor Ortho Biotech and collaborating with Fernando Pisani on the In the Zone for UC program," said Richard Geswell, President of the Crohn's & Colitis Foundation of America. "We are confident that Fernando's success on the ice and in his everyday life will help inspire people living with inflammatory bowel diseases to join the fight in raising awareness and funds for these debilitating and often misunderstood diseases."

About Fernando Pisani

Fernando Pisani first began experiencing the painful symptoms of UC prior to the start of the 2007-08 season. Pisani experienced significant weight loss, fatigue and found it extremely difficult to keep up with the demands of playing professional hockey. The disease eventually caused Fernando to be sidelined for the first 26 games of the season and his return to his team was questionable. Pisani worked closely with his doctor to develop an effective treatment plan that controlled his symptoms and allowed him to return to the ice. In December 2007, Fernando returned to the ice and played the remainder of the season scoring 13 goals and adding nine assists.

About Ulcerative Colitis (UC)

UC, a chronic inflammatory bowel disease affecting nearly 500,000 people in the U.S., is marked by the inflammation and ulceration of the colonic mucosa, or innermost lining, which may lead to bloody stools, severe diarrhea and frequent abdominal pain. Tiny open sores, or ulcers, form on t
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
2. SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility
3. diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
4. Gilead to Topple GSK as the Top Player in the Anti-Infectives Drug Market in 2014
5. Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
6. DrScore.com Partners With Vivacare For Patient Education And Feedback
7. Researchers underscore limitations of genetic ancestry tests
8. Move to AMITIZA Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down
9. SDCRM Receives Highest Score in Three of Four Categories from CIRM on Part I of Major Facilities Grant Application
10. Genomic Health Announces Expansion of Oncotype DX(R) Breast Cancer Test to Include Quantitative Estrogen Receptor (ER) and Progesterone Receptor (PR) Scores
11. Major Independent Study Underscores Utility of deCODE MI(TM) for Better Predicting Risk of Heart Attack, Informing Statin Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22 de enero de 2015  El Dr. Paul ... llamada a nominaciones para 2015. Este prestigioso premio reconoce ... tiene el potencial para hacer, contribuciones destacadas para la ... hasta el 15 de marzo de 2015 a través ...
(Date:1/22/2015)... 22, 2015   GenoSpace , a precision medicine software company ... the broad use of genomic, imaging and other biomedical data ... Michelle Munson , CEO of Aspera, an IBM Company, ... - http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... BOTHELL, Wash. , Dec. 24, 2014   BioLife Solutions ... manufacturer and marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues  ("BioLife" or ... Annual Meeting of Stockholders on May 4, 2015 (the "Annual ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... will be one of the presenters at Digestive Disease ... in interventional gastroenterologyORANGEBURG, S.C., May 29 Zeus, Inc., ... it has been invited to present at Digestive Disease ... Dr. Bruce Anneaux, Ph.D. and GI Endoscopy Specialist Aubrey ...
... May 29 Dey L.P., a subsidiary of Mylan ... it has begun to market and distribute EMSAM(R) in ... monoamine oxidase inhibitor (MAOI), which was approved by the ... the treatment of major depressive disorder. EMSAM previously was ...
... have designed cells that can count and "remember" cellular events, ... activated in a specific order. , Such circuits, which mimic ... the number of times a cell divides, or to study ... biosensors that count exposures to different toxins. , The team ...
Cached Biology Technology:Zeus to Present at Digestive Disease Week in Chicago 2Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder 2MIT, BU engineer cellular circuits that count events 2MIT, BU engineer cellular circuits that count events 3
(Date:1/22/2015)... , Jan. 22, 2015 Infinisource has launched its new ... G2 model. The G2 sets a higher standard for collecting ... capital management solution. With plug-and-play installation, touch screen interface and ... provides a robust time collection solution for the small to ...
(Date:12/22/2014)... 22, 2014  The 2014 Holiday Season may be the ... Intelligence reports that the long anticipated floodgates for consumer ... demand for smart phones, tablets, and wearable mobile devices ... 2.5 billion users with nearly 4.8 billion biometric devices ...
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ...
Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... University School of Medicine studies of Hispanic farmworkers in North ... had skin disease and that workers need more information about ... deadly diseases such as skin cancer. , Few studies have ... Wake Forest studies, 59 farmworkers from Nash and Johnston Counties ...
... most effective chemotherapy drugs against cancer is cisplatin because ... it also kills healthy tissue. Many scientists are creating ... treatments without side effects. One approach to analog development ... a Virginia Tech chemistry-biology research team that has been ...
... ensure complete tumor removal at breast cancer excision is ... used light waves in a newly explored region of ... and determine if the removed tissue margins were clear ... potential to eliminate the need for multiple surgeries and ...
Cached Biology News:Skin disease common among Hispanic farmworkers in North Carolina, research shows 2Light activated anticancer drug targeted to DNA using cisplatin like sub-units 2Terahertz imaging may reduce breast cancer surgeries 2
Human RXR beta/NR2B2 MAb (Clone H7341) Keywords: RXRbeta, RXRbeta, Retinoid X Receptor beta...
Human SOST Affinity Purified Polyclonal Ab...
BOND ELUT MATRIX-C18, 25 mg ...
Prepared from plasminogen by activation with immobilized human uPA...
Biology Products: